Document is current
Any future updates will be listed below
-
Authors
Carlisle, Nicholas A.
Simonsson, Otto
MacCarthy, Sarah
Elliott, Marc N.
Miller, Gabe H.
Goldberg, Simon B.
Shallcross, Ryan A.
Hendricks, Peter S.
-
Funding
Funding for this research was provided by:
Olle Engkvist Foundation
Ekhaga Foundation
Norrsken Mind
National Center for Complementary and Integrative Health (K23AT010879)
Wisconsin Alumni Research Foundation
Wisconsin Center for Education Research
Office of the Vice Chancellor for Research and Graduate Education, University of Wisconsin-Madison
University of Alabama at Birmingham School of Public Health
- License Information
-
More Information
Article History
Received: 24 May 2025
Accepted: 23 January 2026
First Online: 28 January 2026
Declarations
:
: P.S.H. was previously in paid advisory relationships with Eleusis Benefit Corporation, Journey Colab Corporation, Reset Pharmaceuticals Inc., and Silo Pharma, and is currently in paid advisory relationships with Bright Minds Biosciences Ltd. and holds stock options in Beckley Psytech. P.S.H. is also co-founder of Equulus Therapeutics and Mycelial Health. O.S. was a co-founder of Eudelics AB. No financial conflicts of interest were reported by any other authors of this paper.
